ALAB
Astera Labs, Inc.
NASDAQ: ALAB · TECHNOLOGY · SEMICONDUCTORS
$229.67
-11.22% today
Updated 2026-11-02
Market cap
$44.88B
P/E ratio
127.44
P/S ratio
37.34x
EPS (TTM)
$2.03
Dividend yield
—
52W range
$98 – $499
Volume
3.9M
WallStSmart proprietary scores
67
out of 100
Grade: B
Buy
Investment rating
10.0
Growth
A+7.3
Quality
B+8.5
Profitability
A3.0
Valuation
D3/9
Piotroski F-Score
Weak
6.9
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →253 stocks currently score above 75
Price targets
Analyst target
$243.06
+5.83%
12-Month target
$57.10
-75.14%
Intrinsic (DCF)
$144.76
Margin of safety
-78.71%
7 Strong Buy12 Buy7 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 6.86 — safe zone
+ Profit margin 30.70% — above average
+ ROE 21.41% — strong efficiency
+ Free cash flow $67.21M — positive
+ Revenue growth 104.50% QoQ
Risks
- Piotroski 3/9 — weak financial health
- 78.71% above intrinsic value
- P/E 127.44x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $79.87M | $115.79M | $396.29M | $852.52M | $1.20B | $1.6B |
| Net income | $-58.34M | $-26.26M | $-83.42M | $219.13M | $153.09M | — |
| EPS | — | — | — | — | $2.03 | $3.01 |
| Free cash flow | $-39.77M | $-15.48M | $102.43M | $281.76M | $67.21M | — |
| Profit margin | -73.05% | -22.68% | -21.05% | 25.70% | 30.70% | — |
Peer comparison
| Company | Mkt Cap | Score | Growth | Profit | Value | Quality | MoS | Rating |
|---|---|---|---|---|---|---|---|---|
| ALAB | $44.88B | 67 | 10.0 | 8.5 | 3.0 | 7.3 | -78.71% | Strong Buy |
| AAPL | $5.03T | 67 | 6.7 | 10.0 | 3.7 | 6.5 | — | Strong Buy |
| NVDA | $4.94T | 80 | 10.0 | 10.0 | 6.0 | 8.5 | -43.07% | Exceptional Buy |
| MSFT | $3.88T | 72 | 8.7 | 9.5 | 5.0 | 7.0 | — | Strong Buy |
| TSM | $2.27T | 86 | 9.3 | 10.0 | 8.0 | 9.0 | +55.11% | Exceptional Buy |
| AVGO | $1.56T | 80 | 10.0 | 10.0 | 6.3 | 7.0 | — | Exceptional Buy |
Smart narrative
Astera Labs, Inc. trades at $229.67. representing a P/E of 127.44x trailing earnings. Our Smart Value Score of 67/100 indicates the stock is good. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 6.86, it sits in the safe zone. TTM revenue stands at $1.20B. with profit margins at 30.70%. Our DCF model estimates intrinsic value at $144.76.
Frequently asked questions
What is Astera Labs, Inc.'s stock price?
Astera Labs, Inc. (ALAB) trades at $229.67, on a P/E of 127.4x and a P/S of 37.3x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Astera Labs, Inc. overvalued?
Astera Labs, Inc. carries a Smart Value Score of 67/100 (Grade B), which we rate Buy. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $144.76 against the $229.67 price, so on cash flow terms the market is paying a premium for Astera Labs, Inc.'s growth. The Buy rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the price target of Astera Labs, Inc. (ALAB)?
The 12-month analyst consensus target is $243.06, about 5.8% above the current $229.67. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the future stock price of ALAB by 2030?
Our research-backed model puts the 2030 base case at $731.61, built from revenue projections, a growth-adjusted P/S multiple, net debt, and share dilution. It is a scenario rather than a prediction, and the bull and bear cases around it matter more than the single number when you are sizing a position.
What is the intrinsic value of Astera Labs, Inc. (ALAB)?
Our DCF model estimates intrinsic value at $144.76, a -78.7% margin of safety versus today's $229.67. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is Astera Labs, Inc.'s revenue?
Astera Labs, Inc.'s trailing twelve-month revenue is $1.20B, and our model projects it reaching about $6.63B by 2030. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Astera Labs, Inc.'s Altman Z-Score is 6.86, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorTECHNOLOGY
IndustrySEMICONDUCTORS
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio37.34x
ROE21.41%
Beta3.69
50D MA$308.12
200D MA$255.24
Shares out0.17B
Float0.16B
Short ratio—
Avg volume3.9M
Performance
1 week-19.89%
1 month-34.44%
3 months-36.50%
YTD+38.06%
1 year+19.89%
3 years—
5 years—